The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

Cardiovascular diseases are the world's leading cause of death, and high blood pressure, or hypertension, affects more than 1 ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

Key Takeaways Orforglipron becomes first oral GLP-1 receptor agonist to complete Phase 3 trial: Eli Lilly’s once-daily pill ...

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.

Discover effective workouts and physical activities to improve your fitness. Find expert tips on exercises that promote ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...